Home > Drug Search >
  • company_query: AtheroGenics
  •   > 
Drug Filter
Category:
chemistry (19) biology (39)
Status:
Approved (6) Phase Ⅲ (10) Phase Ⅱ (14) Phase Ⅰ (28)
Clinical Stage:
Pending (14) Active (31) Discontinued (7)
Bio-Type:
Gene therapy (1) Vaccine (24) Blood extraction (1) Recombinant coagulation factor (1) Whole antibody (2)
Indication:
Acne (1) Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (3) Atherosclerosis (1) Breast cancer (3) Guillain-Barre syndrome (1) Mucocutaneous lymph node syndrome (Kawasaki syndrome) (1) Agammaglobulinaemia (1) Cognitive disorders (1) Avian influenza (2) Cutaneous T cell lymphoma (CTCL) (1) Diarrhea (2) Gastric cancer (1) HBV infection (2) HCV infection (2) Heart failure (1) HIV infection (5) Influenza virus infection (4) Lung cancer (2) Melanoma (1) Ovarian cancer (1) Pancreatic cancer (1) Parkinson's disease (PD) (2) Pneumonia (1) Diphtheria (2) Pertussis (1) Prostate cancer (1) Tetanus (2) Rejection of organ transplantation (1) Rheumatoid arthritis (RA) (2) Varicella zoster virus infections (1) Middle East respiratory syndrome coronavirus (1) Zika virus infection (1) Solid tumours (3) Rotavirus infection (1) Type 2 diabetes (1) Ulcerative colitis (1) Head and neck cancer (3) Influenza A virus infections (2) Fabry disease (1) Colorectal cancer (1) Anthrax (1) Stroke (1) Cervical carcinoma (1) HER2-positive metastatic breast cancer (1) Malaria (1) Type 1 diabetes (1) Hemophilia A (1) Neutropenia (1) Pruritus (1) Chemotherapy-radiotherapy induced mucositis (1) Gallstone (1) Merkel cell carcinoma (1) Mild cognitive impairment(MCI) (1) Immunodeficiency disorders (1) Thromboembolism (1) Infectious disease (1) Ebola virus disease (EVD) (1) Human papillomavirus infections (HPV) (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top